Acquired Factor V Inhibitor after Coronavirus Disease 2019 (COVID-19).
作者信息
Chiurazzi Federico, Tufano Antonella, Esposito Maria, D'Agostino Francesco, Casoria Aniello, Capasso Filomena, Minno Giovanni Di
机构信息
Department of Hematology and Bone Marrow Transplantation, University of Naples "Federico II," Naples, Italy.
Department of Clinical Medicine and Surgery, University of Naples "Federico II," Naples, Italy.
出版信息
Semin Thromb Hemost. 2022 Feb;48(1):124-126. doi: 10.1055/s-0041-1735452. Epub 2021 Sep 24.
PMID:34560795
Abstract
摘要
相似文献
1
Acquired Factor V Inhibitor after Coronavirus Disease 2019 (COVID-19).2019冠状病毒病（COVID-19）后获得性凝血因子V抑制剂
Semin Thromb Hemost. 2022 Feb;48(1):124-126. doi: 10.1055/s-0041-1735452. Epub 2021 Sep 24.
2
Acquired factor V inhibitor.获得性凝血因子V抑制剂
Intern Med J. 2010 Sep;40(9):667-8. doi: 10.1111/j.1445-5994.2010.02297.x.
3
Iatrogenic acquired factor V inhibitors: A case report and review of the French pharmacovigilance database.
Thromb Res. 2017 Sep;157:154-156. doi: 10.1016/j.thromres.2017.06.007. Epub 2017 Jun 8.
4
Acquired Factor V Inhibitor.获得性凝血因子Ⅴ抑制剂
Intern Med. 2016;55(20):3039-3042. doi: 10.2169/internalmedicine.55.6459. Epub 2016 Oct 15.
5
[Acquired coagulation abnormality due to factor V inhibitor].[因因子V抑制剂导致的获得性凝血异常]
Nihon Naika Gakkai Zasshi. 2002 Nov 10;91(11):3295-7.
6
[Case report; acquired factor V inhibitor with hemoptysis and hematuria].[病例报告；获得性凝血因子V抑制剂伴咯血和血尿]
Nihon Naika Gakkai Zasshi. 2011 Jan 10;100(1):182-4. doi: 10.2169/naika.100.182.
7
Acquired Factor V Inhibitor with Symptoms and Titer of Inhibitor Differences: Report of Two Cases.具有抑制剂症状及滴度差异的获得性因子V抑制剂：两例报告
Acta Haematol. 2019;141(3):148-150. doi: 10.1159/000496080. Epub 2019 Feb 15.
8
9
[Acquired inhibitor of factor V: an uncommon cause of prolonged coagulation tests].[获得性凝血因子V抑制物：凝血试验延长的罕见原因]
Med Clin (Barc). 2006 Mar 11;126(9):359. doi: 10.1157/13085743.
10
Pericardial effusion in a patient with acquired factor V inhibitor.一名获得性因子V抑制剂患者出现心包积液。
Ann Hematol. 2008 Apr;87(4):339-41. doi: 10.1007/s00277-007-0408-1. Epub 2007 Nov 27.
引用本文的文献
1
A First Case Report of Autoimmune Acquired Factor V Deficiency After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccination at the Time of Initiating Haemodialysis.严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗接种后发生自身免疫性获得性因子V缺乏症的首例病例报告——在开始血液透析时。
Nephrology (Carlton). 2025 Feb;30(2):e70003. doi: 10.1111/nep.70003.
2
Delayed spontaneous remission of acquired factor V inhibitor refractory to immunosuppressive therapy with pregnancy-associated improvement.获得性因子 V 抑制剂伴妊娠相关改善，经免疫抑制治疗无效后延迟自发性缓解。
Pathol Oncol Res. 2023 Jun 2;29:1611250. doi: 10.3389/pore.2023.1611250. eCollection 2023.
3
Autoimmune Diseases Affecting Hemostasis: A Narrative Review.自身免疫性疾病对止血的影响：一篇叙述性综述。
Int J Mol Sci. 2022 Nov 25;23(23):14715. doi: 10.3390/ijms232314715.
4
Coagulation factor inhibitors in COVID-19: From SARS-CoV-2 vaccination to infection.新冠病毒感染中的凝血因子抑制剂：从接种严重急性呼吸综合征冠状病毒2疫苗到感染
Res Pract Thromb Haemost. 2022 Apr 14;6(3):e12700. doi: 10.1002/rth2.12700. eCollection 2022 Mar.
Zotero 插件